Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

Frequency of Eye Diseases in Subjects Aged 40 and Over. Open Journal of Ophthalmology, 15, 11-17. doi: ...

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

A retrospective study reveals the COVID-19 pandemic significantly reduced the frequency of common ophthalmic procedures, ...

Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...

According to the company, the suffix “-mod” in urcosimod denotes its classification as a modulator of key inflammatory and ...

Scleral thickness reductions in patients with keratoconus suggest that the disorder's pathogenesis is not limited to the cornea.

ARLINGTON, Mass. - KALA BIO, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on developing treatments for rare and severe eye diseases, announced a change in its executive leadership on Monday ...

LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company specializing in the development of treatments for ocular conditions and currently valued at $37 million, has ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...